Overview

Comparative Bioequivalence Study in Adult Patients Suffering From Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor Under Fed Conditions

Status:
Completed

Trial end date:
2014-06-01

Target enrollment:

Participant gender:

Summary

To characterize pharmacokinetic profile of test product compared to that of the corresponding reference product in adult patients, who are diagnosed to have Chronic Myeloid Leukemia & Gastrointestinal Stromal Tumor under Fed Conditions.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Amneal Pharmaceuticals, LLC

Collaborator:

Accutest Research Laboratories (I) Pvt. Ltd.

Treatments:

Imatinib Mesylate